Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Kramer

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Urologie (Heidelberg, Germany)|August 20, 2025
[Update guideline on prostate cancer-balancing act between evidence and healthcare reality]Axel Belusa, Peter J Goebell, Peter Kollenbach, et al.
Aktuelle Urologie|June 25, 2024
[Therapy sequences and duration in mCRPC: a retrospective review of the Lübeck mCRPC cohort]Marten Müller, Semih Sarcan, Anne Offermann, et al.
Oncology Reports|April 22, 2008
PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activationJoerg Hennenlotter, Petra A Ohneseit, Perikles Simon, et al.
Urologia Internationalis|March 7, 2018
Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current PracticeSerkan Dogan, Martin Hennig, Tanja Frank, et al.
Aktuelle Urologie|August 6, 2025
Economics, Ergonomics, Effectiveness: A Monocentric Comparison of Single-Use vs. Reusable Flexible Ureteroscopes in Challenging Kidney Stone CasesTomasz Ozimek, Karsten Günzel, Natasza Galuszka-Ozimek, et al.
World Journal of Urology|October 12, 2012
Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case reportInga Peters, Michael Winkler, Björn Jüttner, et al.
Journal for Immunotherapy of Cancer|January 10, 2023
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitorsAristotelis Bamias, Axel Merseburger, Yohann Loriot, et al.
The Journal of Biological Chemistry|August 23, 2008
Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoterVinata B Lokeshwar, Pablo Gomez, Mario Kramer, et al.
World Journal of Urology|August 16, 2023
En bloc resection of bladder tumour: the rebirth of past through reminiscenceJeremy Yuen-Chun Teoh, David D'Andrea, Andrea Gallioli, et al.
BJU International|February 16, 2026
Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancerMulham Al-Nader, Claudia Kesch, Osama Mahmoud, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Urologie (Heidelberg, Germany)|August 20, 2025
[Update guideline on prostate cancer-balancing act between evidence and healthcare reality]Axel Belusa, Peter J Goebell, Peter Kollenbach, et al.
Aktuelle Urologie|June 25, 2024
[Therapy sequences and duration in mCRPC: a retrospective review of the Lübeck mCRPC cohort]Marten Müller, Semih Sarcan, Anne Offermann, et al.
Oncology Reports|April 22, 2008
PTEN and p27Kip1 are not downregulated in the majority of renal cell carcinomas--implications for Akt activationJoerg Hennenlotter, Petra A Ohneseit, Perikles Simon, et al.
Urologia Internationalis|March 7, 2018
Acceptance of Adjuvant and Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer in Germany: A Survey of Current PracticeSerkan Dogan, Martin Hennig, Tanja Frank, et al.
Aktuelle Urologie|August 6, 2025
Economics, Ergonomics, Effectiveness: A Monocentric Comparison of Single-Use vs. Reusable Flexible Ureteroscopes in Challenging Kidney Stone CasesTomasz Ozimek, Karsten Günzel, Natasza Galuszka-Ozimek, et al.
World Journal of Urology|October 12, 2012
Neoadjuvant targeted therapy in a primary metastasized renal cell cancer patient leads to down-staging of inferior vena cava thrombus (IVC) enabling a cardiopulmonary bypass-free tumor nephrectomy: a case reportInga Peters, Michael Winkler, Björn Jüttner, et al.
Journal for Immunotherapy of Cancer|January 10, 2023
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitorsAristotelis Bamias, Axel Merseburger, Yohann Loriot, et al.
The Journal of Biological Chemistry|August 23, 2008
Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoterVinata B Lokeshwar, Pablo Gomez, Mario Kramer, et al.
World Journal of Urology|August 16, 2023
En bloc resection of bladder tumour: the rebirth of past through reminiscenceJeremy Yuen-Chun Teoh, David D'Andrea, Andrea Gallioli, et al.
BJU International|February 16, 2026
Patient-reported outcomes: active surveillance vs radical therapies in low-risk prostate cancerMulham Al-Nader, Claudia Kesch, Osama Mahmoud, et al.
Pageof 2